Searchable Alterations Database
Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).
| Marker / Test | Direction | Category | vs. Comparison | Clinical Context | Key Reference |
|---|
Molecular alterations reported in NAFLD / MASH (Metabolic-Associated Steatohepatitis) compared to healthy controls, from peer-reviewed literature.
Biomarkers below are included only where peer-reviewed literature explicitly reports the marker's direction in NAFLD / MASH (Metabolic-Associated Steatohepatitis) patients relative to a named comparison population — not inferred.
Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).
| Marker / Test | Direction | Category | vs. Comparison | Clinical Context | Key Reference |
|---|